Janice Bereskin discusses the importance of securing a .CA domain with Law Times
In a recent article published by Law Times in partnership with CIRA, Janice Bereskin provides insight into the advantages of securing a .CA domain. “My advice is simple: any company planning to enter the Canadian marketplace should secure the .CA early on,” Janice Bereskin says, adding that the risk companies face if they don’t is that another entity will beat them to it, making it costly—or simply impossible—to obtain it later.
The article highlights IP lawyers’ key role in helping clients secure their Canadian digital identity by securing a .CA domain. Janice Bereskin points out that securing a .CA domain should be part of the standard consultation process after a trademark clearance search. “Reviewing and securing a .CA, in addition to other top level domain names and social media handles, once they have conducted a full trademark clearance search, should be table stakes in any consultation,” Janice Bereskin notes. “That said, clients and the stage they’re at may differ and it’s important to find out what they already own and who is managing their digital assets.”
CIRA’s “Lock down the .CA domain” campaign further reinforces the benefits of securing a .CA domain, which not only increases visibility but also protects businesses from threats such as domain squatting, phishing, and fraud.
Related News & Media
-
Melanie Szweras on certifying data breach class actions for Lexpert
Recently, Principal Melanie Szweras spoke with Jessica Mach from Lexpert on some of the challenges that arise in certifying data breach class actions.Read More -
Melanie Szweras and Patrick Roszell talk AI and Health Privacy with Lexpert
Recently Smart & Biggar Principals Patrick Roszell and Melanie Szweras sat down with Lexpert’s Zena Olijnyk to discuss the privacy impacts caused by the increasing use of artificial intelligence (...Read More -
Noel Courage quoted in Lexpert on licensing gains as patent expiries loom
Smart & Biggar Principal Noel Courage recently discussed licensing trends with Lexpert, noting that start-ups and academic institutions remain key innovation sources in the pharma and biopharmaceu...Read More